Drug manufacturer to launch commercial version of ‘natural painkiller’ Palmitoylethanolamide (PEA)

A large U.S. pharmaceutical company is preparing to go to market with a mass-produced commercial version of a natural pain management supplement that compounding pharmacies in Australia have been providing to integrative doctors and their patients for many years – Palmitoylethanolamide, or PEA. In November the drug manufacturer, Gencor, announced it had recently completed a 

Continue Reading…

Compounded medication is about to get even safer

The world’s leading authority on safety in drug manufacturing, United States Pharmacopeia (USP), has announced that this year they will be updating their standards for the compounding of medications in traditional compounding pharmacies. Specialist pharmacist Matthew Bellgrove from National Custom Compounding welcomed the news saying it would help to build trust in the sector. “Anything 

Continue Reading…